EPS Diluted (TTM) Chart

Historical EPS Diluted (TTM) Data

View and export this data back to 2016. Start Trial.
Date Value
June 30, 2026 -3.357
March 31, 2026 -3.534
December 31, 2025 -3.827
September 30, 2025 -4.266
June 30, 2025 -4.690
March 31, 2025 -5.229
December 31, 2024 -5.250
September 30, 2024 -5.445
June 30, 2024 -5.480
March 31, 2024 -5.367
December 31, 2023 -5.417
September 30, 2023 -5.352
June 30, 2023 -5.462
March 31, 2023 -5.388
December 31, 2022 -6.178
September 30, 2022 -5.873
June 30, 2022 -5.356
March 31, 2022 -5.038
December 31, 2021 -3.761
September 30, 2021 -3.357
June 30, 2021 -2.859
Date Value
March 31, 2021 -2.457
December 31, 2020 -2.399
September 30, 2020 -2.284
June 30, 2020 -2.297
March 31, 2020 -2.250
December 31, 2019 -2.105
September 30, 2019 -1.964
June 30, 2019 -2.007
March 31, 2019 -1.966
December 31, 2018 -1.991
September 30, 2018 -2.17
June 30, 2018 -2.08
March 31, 2018 -2.01
December 31, 2017 -1.86
September 30, 2017 -1.56
June 30, 2017 -1.34
March 31, 2017 -1.25
December 31, 2016 -10.78
September 30, 2016 -10.47
June 30, 2016 -10.25
March 31, 2016 -9.89

EPS Diluted (TTM) Range, Past 5 Years

View EPS Diluted (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (TTM) Benchmarks

View EPS Diluted (TTM) Benchmarks
Start Trial
Twist Bioscience Corp. -2.224
Beam Therapeutics, Inc. -0.86
Prime Medicine, Inc. -1.086
Moderna, Inc. -7.985
Q32 Bio, Inc. 3.001